Hyperhomocyst(e)inemia presenting as multisite vascular thrombosis

Indian Heart Journal

Volumn 52, Issue 5, 2000, Pages 587-591

  Singh, Sandeep ^b   Kumar, Ashish ^b   Jaishankar, K ^b   Gambhir, J K ^b   Gambhir, D S ^a   Arora, R ^b  

^a G B PANT HOSPITAL   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; CASE REPORT; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOGRAPHY; THROMBOSIS;

ADULT; CORONARY ANGIOGRAPHY; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MAGNETIC RESONANCE IMAGING; MALE; PHLEBOGRAPHY; THROMBOSIS;

EID: 0034280164     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Woo KS, Chook P, Lolin YL. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J Am Coll Cardiol 1999; 34: 2002-2006
2. Malinow MR. Hyperhomocystinemia: A common and easily reversible risk factor for occlusive atherosclerosis. Circulation 1990; 81: 2004-2006
3. Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996; 27: 517-527
4. Falcon CR, Cattaneo M, Panzeri D, et al. High prevalence of hyperhomocystinemia in patients with juvenile venous thrombosis. Arterioscler Thromb 1994; 14: 1080-1083
5. Fermo I, Vigano DAS, Paroni R, et al. Prevalance of moderate hyperhomocystinemia in patients with early onset venous and arterial occlusive disease. Ann Intern Med 1995; 123: 747-753
6. Heijer M den, Blom HJ, Gerrits WBJ, et al. Is hyperhomocystinemia a risk factor for recurrent venous thrombosis? Lancet 1995; 345: 882-885
7. Heijer M den, Koster T, Blom HJ, et al. Hyperhomocystinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759-762
8. Cattaneo M, Martinelli I, Mannucci PM. Hyperhomocystinemia as a risk factor for deep vein thrombosis. N Engl J Med 1996; 335: 974-975
9. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem 1990; 1: 228-237
10. McCully KS. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111-128
11. Mudd SH, Skovby F, Levy Hi, et al. The natural history of homocystinuria due to cystathione beta-synthetase deficiency. Am J Hum Gen 1985; 37: 1-31
12. Wald NJ, Watt HC, Law MR, et al. Homocysteine and ischaemic heart disease: Results of a prospective study with implications on prevention. Arch Int Med 1998; 158: 862-867
13. Kang SS, Wong PWK, Malinow MR. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Ann Rev Nutr 1992; 12: 279-298
14. Ueland PM, Refsum H, Stabler SP, et al. Total homocysteine in plasma or serum: Methods and clinical applications. Clin Chem 1993; 39: 1764-1779
15. Makris M. Hyperhomocystinemia and thrombosis. Clin Lab Haem 2000; 22: 133-143
16. Cattaneo M. Hyperhomocystinemia, atherosclerosis and thrombosis. Thromb Haemost 1999;81:165-176
17. Welch GN, Loscalzo J. Homocysteine and atherosclerosis. N Engl J Med 1998; 338: 1042-1050
18. Frauscher G, Karnaukova E, Muehl A, et al. Oral administration of homocysteine leads to increased plasma triglyceride and homocysteic acid: Additional mechanisms in homocysteine induced endothelial damage. Life Sciences 1995; 57: 813-817
19. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia : An independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-1155
20. Tsai JC, Perrella MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine : A link to atherosclerosis. Proc Nat Acad Sci USA 1994; 91: 6369-6373
21. Selhub J, Jacques PF, Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly populations. JAMA 1993; 270: 2693-2698
22. Chambers JC, Obeid OA, Refsu H, et al. Plasma homocysteine concentration and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000; 355: 523-527
23. Matthews JH, Wood JK. Megaloblastic anaemia in vegetarian Asians. Clin Lab Haematol 1984; 6: 1-7
24. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-1057
25. Nygard O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230-236
26. Bostom AG, Rosenbarg IH, Sibershatz H. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham study. Ann Int Med 1999; 131: 352-355
27. Clarke R, Armitage J. Vitamin supplements and cardiovascular risk: Review of randomized trials of homocysteine lowering vitamin supplements. Semin Thromb Haemost 2000; 26: 341-348
28. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomized trials. The Homocysteine Lowering Trialists' Collaboration. Br Med J 1998; 316: 894-898
29. Brouwer IA. Low dose folic acid supplementation decreases plasma homocysteine concentrations : A randomized trial. Am J Clin Nutr 1999; 69: 99-104